nach oben

Erschienen in:

28.12.2017 | Original Paper

Socioeconomic Disparities and Metabolic Risk in Veterans with Serious Mental Illness

verfasst von: Stanley N. Caroff, Shirley H. Leong, Daisy Ng-Mak, E. Cabrina Campbell, Rosalind M. Berkowitz, Krithika Rajagopalan, Chien-Chia Chuang, Antony Loebel

Erschienen in: Community Mental Health Journal | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Socioeconomic disparities were assessed in predicting metabolic risk among veterans with serious mental illness. Veterans with schizophrenia, schizoaffective, or bipolar disorders were identified in VISN 4 facilities from 10/1/2010 to 9/30/2012. Differences between patients with and without metabolic syndrome were compared using t-tests, Chi square tests and multivariate logistic regressions. Among 10,132 veterans with mental illness, 48.8% had metabolic syndrome. Multivariate logistic regression analysis confirmed that patients with metabolic syndrome were significantly more likely to be older, male, African-American, married, and receiving disability pensions but less likely to be homeless. They were more likely to receive antipsychotics, antidepressants, or anticonvulsants. Bivariate cross-sectional analysis revealed that patients with metabolic syndrome had higher rates of coronary artery disease, cerebrovascular disease, and mortality, and that metabolic syndrome was more often associated with emergency visits and psychiatric or medical hospitalizations. Demographics, socioeconomic status and medications are independent predictors of metabolic syndrome and should be considered in broader screening of risk factors in order to provide preventive interventions for metabolic syndrome.

Administration Update of VA Veterans Health, & About the VA Healthcare-VISN 4. Accessed August 19 2016.

Aguilar, M., Bhuket, T., Torres, S., Liu, B., & Wong, R. J. (2015). Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA, 313(19), 1973–1974. https://doi.org/10.1001/jama.2015.4260.CrossRefPubMed

Alberti, K.G., & Zimmet, P.Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15(7), 539–553. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed

Baicker, K., Chandra, A., & Skinner, J. S. (2005). Geographic variation in health care and the problem of measuring racial disparities. Perspectives in Biology and Medicine, 48(1 Suppl), S42–S53.CrossRefPubMed

Batki, S. L., Meszaros, Z. S., Strutynski, K., Dimmock, J. A., Leontieva, L., Ploutz-Snyder, R., et al. (2009). Medical comorbidity in patients with schizophrenia and alcohol dependence. Schizophrenia Research, 107(2–3), 139–146. https://doi.org/10.1016/j.schres.2008.10.016.CrossRefPubMed

Brown, S., Kim, M., Mitchell, C., & Inskip, H. (2010). Twenty-five year mortality of a community cohort with schizophrenia. The British Journal of Psychiatry, 196(2), 116–121. https://doi.org/10.1192/bjp.bp.109.067512.CrossRefPubMedPubMedCentral

Byrne, B., Montgomery, A. E., Treglia, D., Roberts, C. B., & Culhane, D. P. (2013). Health services use among veterans using U.S. Department of Veterans Affairs mainstream homeless services. World Medical & Health Policy, 5(4), 347–361.CrossRef

Casey, D. E., Haupt, D. W., Newcomer, J. W., Henderson, D. C., Sernyak, M. J., Davidson, M., et al. (2004). Antipsychotic-induced weight gain and metabolic abnormalities: Implications for increased mortality in patients with schizophrenia. The Journal of Clinical Psychiatry, 65(Suppl 7), 4–18; quiz 19–20.PubMed

Chetty, R., Stepner, M., Abraham, S., Lin, S., Scuderi, B., Turner, N., et al. (2016). The association between income and life expectancy in the United States, 2001–2014. JAMA, 315(16), 1750–1766. https://doi.org/10.1001/jama.2016.4226.CrossRefPubMedPubMedCentral

Chwastiak, L. A., Rosenheck, R. A., Desai, R., & Kazis, L. E. (2010). Association of psychiatric illness and all-cause mortality in the National Department of Veterans Affairs Health Care System. Psychosomatic Medicine, 72(8), 817–822. https://doi.org/10.1097/PSY.0b013e3181eb33e9.CrossRefPubMedPubMedCentral

Copeland, L. A., Zeber, J. E., Wang, C. P., Parchman, M. L., Lawrence, V. A., Valenstein, M., et al. (2009). Patterns of primary care and mortality among patients with schizophrenia or diabetes: A cluster analysis approach to the retrospective study of healthcare utilization. BMC Health Services Research, 9, 127. https://doi.org/10.1186/1472-6963-9-127.CrossRefPubMedPubMedCentral

Correll, C. U., Frederickson, A. M., Kane, J. M., & Manu, P. (2006). Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. The Journal of Clinical Psychiatry, 67(4), 575–583.CrossRefPubMed

Correll, C. U., Frederickson, A. M., Kane, J. M., & Manu, P. (2007). Does antipsychotic polypharmacy increase the risk for metabolic syndrome? Schizophrenia Research, 89(1–3), 91–100. https://doi.org/10.1016/j.schres.2006.08.017.CrossRefPubMed

Correll, C. U., Robinson, D. G., Schooler, N. R., Brunette, M. F., Mueser, K. T., Rosenheck, R. A., et al. (2014). Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: Baseline results from the RAISE-ETP study. JAMA Psychiatry, 71(12), 1350–1363. https://doi.org/10.1001/jamapsychiatry.2014.1314.CrossRefPubMed

Cullen, B. A., McGinty, E. E., Zhang, Y., Dosreis, S. C., Steinwachs, D. M., Guallar, E., et al. (2013). Guideline-concordant antipsychotic use and mortality in schizophrenia. Schizophrenia Bulletin, 39(5), 1159–1168. https://doi.org/10.1093/schbul/sbs097.CrossRefPubMed

Dickey, B., Normand, S. L., Weiss, R. D., Drake, R. E., & Azeni, H. (2002). Medical morbidity, mental illness, and substance use disorders. Psychiatric Services, 53(7), 861–867.CrossRefPubMed

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 285, 2486–2497.CrossRef

Fagiolini, A., Frank, E., Houck, P. R., Mallinger, A. G., Swartz, H. A., Buysse, D. J., et al. (2002). Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. The Journal of Clinical Psychiatry, 63(6), 528–533.CrossRefPubMed

Gale, C. R., Batty, G. D., Osborn, D. P., Tynelius, P., Whitley, E., & Rasmussen, F. (2012). Association of mental disorders in early adulthood and later psychiatric hospital admissions and mortality in a cohort study of more than 1 million men. Archives of General Psychiatry, 69(8), 823–831. https://doi.org/10.1001/archgenpsychiatry.2011.2000.CrossRefPubMedPubMedCentral

Goethe, J. W., Szarek, B. L., Caley, C. F., & Woolley, S. B. (2007). Signs and symptoms associated with the metabolic syndrome in psychiatric inpatients receiving antipsychotics: A retrospective chart review. The Journal of Clinical Psychiatry, 68(1), 22–28.CrossRefPubMed

Hudson, C. G. (2005). Socioeconomic status and mental illness: Tests of the social causation and selection hypotheses. American Journal of Orthopsychiatry, 75(1), 3–18. https://doi.org/10.1037/0002-9432.75.1.3.CrossRefPubMed

Kilbourne, A. M., Morden, N. E., Austin, K., Ilgen, M., McCarthy, J. F., Dalack, G., et al. (2009). Excess heart-disease-related mortality in a national study of patients with mental disorders: Identifying modifiable risk factors. General Hospital Psychiatry, 31(6), 555–563. https://doi.org/10.1016/j.genhosppsych.2009.07.008.CrossRefPubMedPubMedCentral

Levine, J. A. (2011). Poverty and obesity in the U.S. Diabetes, 60(11), 2667–2668. https://doi.org/10.2337/db11-1118.CrossRefPubMedPubMedCentral

McElroy, S. L., & Keck, P. E. Jr. (2014). Metabolic syndrome in bipolar disorder: A review with a focus on bipolar depression. The Journal of Clinical Psychiatry, 75(1), 46–61. https://doi.org/10.4088/JCP.13r08634.CrossRefPubMed

McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., et al. (2005). Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research, 80(1), 19–32. https://doi.org/10.1016/j.schres.2005.07.014.CrossRefPubMed

McIntyre, R. S., Park, K. Y., Law, C. W., Sultan, F., Adams, A., Lourenco, M. T., et al. (2010). The association between conventional antidepressants and the metabolic syndrome: A review of the evidence and clinical implications. CNS Drugs, 24(9), 741–753. https://doi.org/10.2165/11533280-000000000-00000.CrossRefPubMed

McMillan, K. A., Enns, M. W., Asmundson, G. J., & Sareen, J. (2010). The association between income and distress, mental disorders, and suicidal ideation and attempts: Findings from the Collaborative Psychiatric Epidemiology Surveys. The Journal of Clinical Psychiatry, 71(9), 1168–1175. https://doi.org/10.4088/JCP.08m04986gry.CrossRefPubMed

Meyer, J., Loh, C., Leckband, S. G., Boyd, J. A., Wirshing, W. C., Pierre, J. M., et al. (2006). Prevalence of the metabolic syndrome in veterans with schizophrenia. Journal of Psychiatric Practice, 12(1), 5–10.CrossRefPubMed

Meyer, J. M., Rosenblatt, L. C., Kim, E., Baker, R. A., & Whitehead, R. (2009). The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia. The Journal of Clinical Psychiatry, 70(3), 318–325.CrossRefPubMed

Miranda, J., McGuire, T. G., Williams, D. R., & Wang, P. (2008). Mental health in the context of health disparities. American Journal of Psychiatry, 165(9), 1102–1108. https://doi.org/10.1176/appi.ajp.2008.08030333.CrossRefPubMed

Morden, N. E., Lai, Z., Goodrich, D. E., MacKenzie, T., McCarthy, J. F., Austin, K., et al. (2012). Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia. General Hospital Psychiatry, 34(4), 368–379. https://doi.org/10.1016/j.genhosppsych.2012.02.009.CrossRefPubMedPubMedCentral

Osborn, D. P., Hardoon, S., Omar, R. Z., Holt, R. I., King, M., Larsen, J., et al. (2015). Cardiovascular risk prediction models for people with severe mental illness: Results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program. JAMA Psychiatry, 72(2), 143–151. https://doi.org/10.1001/jamapsychiatry.2014.2133.CrossRefPubMedPubMedCentral

Rogers, R., Eagle, T. F., Sheetz, A., Woodward, A., Leibowitz, R., Song, M., et al. (2015). The relationship between childhood obesity, low socioeconomic status, and race/ethnicity: Lessons from Massachusetts. Childhood Obesity, 11(6), 691–695. https://doi.org/10.1089/chi.2015.0029.CrossRefPubMedPubMedCentral

Rosenbaum, S., Stubbs, B., Ward, P. B., Steel, Z., Lederman, O., & Vancampfort, D. (2015). The prevalence and risk of metabolic syndrome and its components among people with posttraumatic stress disorder: A systematic review and meta-analysis. Metabolism, 64(8), 926–933. https://doi.org/10.1016/j.metabol.2015.04.009.CrossRefPubMed

Scott, K. M., Al-Hamzawi, A. O., Andrade, L. H., Borges, G., Caldas-de-Almeida, J. M., Fiestas, F., et al. (2014). Associations between subjective social status and DSM-IV mental disorders: Results from the World Mental Health surveys. JAMA Psychiatry, 71(12), 1400–1408. https://doi.org/10.1001/jamapsychiatry.2014.1337.CrossRefPubMedPubMedCentral

Segal, S. P., & Kotler, P. L. (1991). A ten-year perspective of mortality risk among mentally ill patients in sheltered care. Hospital & Community Psychiatry, 42(7), 708–713.

Torniainen, M., Mittendorfer-Rutz, E., Tanskanen, A., Bjorkenstam, C., Suvisaari, J., Alexanderson, K., et al. (2015). Antipsychotic treatment and mortality in schizophrenia. Schizophrenia Bulletin, 41(3), 656–663. https://doi.org/10.1093/schbul/sbu164.CrossRefPubMed

United States Department of Veterans Affairs. (2013a). Decision Support System Outpatient Identifiers. Washington, D.C. https://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=1788.

United States Department of Veterans Affairs. (2013b). Priority Group Tables. Washington, D.C. http://www.va.gov/healthbenefits/resources/priority_groups.

Vancampfort, D., Vansteelandt, K., Correll, C. U., Mitchell, A. J., De Herdt, A., Sienaert, P., et al. (2013). Metabolic syndrome and metabolic abnormalities in bipolar disorder: A meta-analysis of prevalence rates and moderators. American Journal of Psychiatry, 170(3), 265–274. https://doi.org/10.1176/appi.ajp.2012.12050620.CrossRefPubMed

Wakabayashi, I. (2014). Frequency of heavy alcohol drinking and risk of metabolic syndrome in middle-aged men. Alcoholism: Clinical and Experimental Research, 38(6), 1689–1696. https://doi.org/10.1111/acer.12425.CrossRef

Walker, E. R., McGee, R. E., & Druss, B. G. (2015). Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis. JAMA Psychiatry, 72(4), 334–341. https://doi.org/10.1001/jamapsychiatry.2014.2502.CrossRefPubMedPubMedCentral

Wilson, P. W. (2004). Estimating cardiovascular disease risk and the metabolic syndrome: A Framingham view. Endocrinology and Metabolism Clinics, 33(3), 467–481. https://doi.org/10.1016/j.ecl.2004.03.012.

World Health Organization, & International Classification of Diseases, N.R. Accessed August 19 2016.

Zivin, K., Bohnert, A. S., Mezuk, B., Ilgen, M. A., Welsh, D., Ratliff, S., et al. (2011). Employment status of patients in the VA health system: Implications for mental health services. Psychiatric Services, 62(1), 35–38. https://doi.org/10.1176/appi.ps.62.1.35.CrossRefPubMed

Titel: Socioeconomic Disparities and Metabolic Risk in Veterans with Serious Mental Illness
verfasst von: Stanley N. Caroff
Shirley H. Leong
Daisy Ng-Mak
E. Cabrina Campbell
Rosalind M. Berkowitz
Krithika Rajagopalan
Chien-Chia Chuang
Antony Loebel
Publikationsdatum: 28.12.2017
Verlag: Springer US
Erschienen in: Community Mental Health Journal / Ausgabe 6/2018
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-017-0215-7

Neu im Fachgebiet Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Socioeconomic Disparities and Metabolic Risk in Veterans with Serious Mental Illness

Abstract

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Acceptability of Mental Health Services for Anxiety and Depression in an Arab Sample

Monitoring and Treating Metabolic Abnormalities in Patients with Early Psychosis Initiated on Antipsychotic Medications

The Role of Public Health in the Development of a Collaborative Agreement with Rural and Semi-urban Partners in Cases of Severe Domestic Squalor and Hoarding

Preferences for Depression Help-Seeking Among Vietnamese American Adults

The Association Between Social Network Factors with Depression and Anxiety at Different Life Stages

Public Awareness and Attitude Towards Depression: A Community Based Study Among an Adult Population in Ile-Ife South-Western Nigeria

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie